Product Information

GABAPENTIN 800 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0858 per EA under NDC 82009007205. Its NADAC has been published 159 times since Nov 8, 2023.

FDA first approved this application on Oct 6, 2011. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GABAPENTIN 800 MG TABLET

Gabapentin
$0.0858per EA

Strength

800 mg/1

NDC

82009007205

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA200651

FDA Approved

10/6/2011

TE Code

AB1

On Market Since

9/1/2023

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 800 MG TABLET has been published 159 times since Nov 8, 2023, and over the history we have for it it has declined 31.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0858 per EA
All-time high$0.1275 (Jan 10, 2024)
All-time low$0.0799 (Nov 20, 2024)
52-week high$0.1015
52-week low$0.0858
Median price$0.1016
Average price$0.1031
Largest weekly change-27.0% (Nov 20, 2024)
Weeks tracked159
Tracking sinceNov 8, 2023

Price History

1W

-0.2%

1M

-2.8%

3M

-4.7%

6M

-12.4%

1Y

-15.4%

3Y

-31.4%

5Y

N/A

All

-31.4%

Generic Alternatives

The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GABAPENTIN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0858 per EA (NDC 82009007205), effective Nov 18, 2026.

How has the price of GABAPENTIN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 31.4%. It has been tracked across 159 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?

Since Nov 8, 2023, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1275 (Jan 10, 2024), with a median of $0.1016 per EA.

Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?

20 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 800 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 800 MG TABLET?

GABAPENTIN 800 MG TABLET (NDC 82009007205) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.